Anti-tumor angiogenesis with a recombinant ag43/FGFR1 chimeric protein as a model antigen

@article{2010AntitumorAW,
  title={Anti-tumor angiogenesis with a recombinant ag43/FGFR1 chimeric protein as a model antigen},
  author={Shaoping Zheng 郑少萍 and Zhihong Weng 翁志宏 and Shaojiang Zheng 郑少江 and Junli Guo 郭峻莉 and Fengying Huang 黄风迎 and Mingxing Xie 谢明星},
  journal={Journal of Huazhong University of Science and Technology [Medical Sciences]},
  year={2010},
  volume={30},
  pages={25-28}
}
In order to investigate the anti-tumor angiogenesis activity with a recombinant Ag43/FGFR1 chimeric protein (AF) vaccine in a mouse H22 hepatoma model, tumor volume and survival rate of the mice were studied at a 3-day interval. Microvessel density (MVD) was detected by immunohistochemistry. The endothelial deposition of autoantibodies within tumor tissues… CONTINUE READING